There are still widespread shortages of critical chemotherapy drugs, although the situation is improving slightly, according to data released Thursday by the National Comprehensive Cancer Network.
Among 29 cancer centers across the U.S., 72% reported a shortage of the chemotherapy medication carboplatin, while 59% reported a shortage of the drug cisplatin.
When surveyed earlier this summer, 93% of cancer centers said they were experiencing a shortage of carboplatin and 70% were experiencing a shortage of cisplatin. "These new survey results remind us that we are still in an ongoing crisis and must respond with appropriate urgency." Oncologist Robert Carlson, NCCN's chief executive officer, told Stat News it will likely take federal action to change the situation.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. cancer centers report fewer drug shortages, but crisis continuesThe shortfalls are far from resolved, a new survey of leading cancer centers found.
Read more »
Surprise homecoming for teen cancer patient, breast cancer myths and tips for better sleepThe Fox News Health Newsletter brings you trending and important stories about health warnings, drug shortages, mental health issues and more in this weekly recap.
Read more »
Women living in more walkable neighborhoods have lower rates of obesity-related cancersResiding in a more walkable neighborhood protects against the risk of overall obesity-related cancers in women, specifically postmenopausal breast cancer, but also ovarian cancer, endometrial cancer, and multiple myeloma, according to a new study. Obesity has been linked to increased risk for 13 types of cancer in women, and physical activity, independent of body size, lowers risk for some of these cancers. Until now long-term studies of neighborhood walkability and risk for obesity-related cancer were limited.
Read more »
Postdoctoral Fellow – Molecular drivers of melanoma progression - Tampa, Florida job with H. Lee Moffitt Cancer Center & Research Institute | 12807187At Moffitt Cancer Center, we come face-to-face with cancer every day, but we also see courage. And it inspires us to be the safest and best place for cancer care – to bring greater hope to every patient we serve. It’s why we’ve been continually named One of the Top Places to Work in the Tampa Bay Area. As the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, Moffitt employs some of the best and brightest minds from around the world. Moffitt is the leading cancer hospital in both Florida and the Southeast and has been nationally ranked by U.S. News & World Report since 1999. Because working at Moffitt is both a career and a mission: to contribute to the prevention and cure of cancer. Join a dedicated, diverse and inclusive team of over 7,000 to be a part of the Courageous future we envision.\r\n\r\nSummary\r\n\r\nPostdoctoral Fellow – Molecular drivers of melanoma progression\r\n\r\nA fully funded postdoctoral position is available in the laboratory of Florian A. Karreth, PhD in the Department of Molecular Oncology at Moffitt Cancer Center in Tampa, FL. The Karreth lab studies the molecular and genetic mechanisms promoting melanoma progression, metastasis, and drug resistance. We are recruiting a postdoctoral fellow to work on glycol-RNA at the intersection of glycobiology and RNA biology in the context of melanoma. This project is funded by the Department of Defense and will involve the characterization of glycoRNA formation and function and their role in mediating melanoma progression and metastasis by affecting interactions with the tumor microenvironment and immune system. The successful candidate will use a variety of cell biological, molecular biological, and biochemical methods, and generate innovative genetically engineered mouse models to better understand glycoRNAs in the context of spontaneous melanoma development. The ultimate goal is to identify vulnerabilities and opportunities for therapeutic targeting, and novel t
Read more »
Breast Cancer Awareness Month: Early detection is key to survivalBreast cancer is the most common cancer among women in Ohio, accounting for 29% of all new female invasive cancer cases, according to the Ohio Department of Health.
Read more »
Martina Navratilova urges all women to get cancer screenings: \u2018It's a question of life and death'For Breast Cancer Awareness month, Martina Navratilova urges women to be diligent about preventive care and cancer screenings after battling two forms of cancer\u2026
Read more »